BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38016026)

  • 1. Targeted epigenetic silencing of UCHL1 expression suppresses collagen-1 production in human lung epithelial cells.
    Wu DD; Lau ATY; Xu YM; Reinders-Luinge M; Koncz M; Kiss A; Timens W; Rots MG; Hylkema MN
    Epigenetics; 2023 Dec; 18(1):2175522. PubMed ID: 38016026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors.
    Yu J; Tao Q; Cheung KF; Jin H; Poon FF; Wang X; Li H; Cheng YY; Röcken C; Ebert MP; Chan AT; Sung JJ
    Hepatology; 2008 Aug; 48(2):508-18. PubMed ID: 18666234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma.
    Seliger B; Handke D; Schabel E; Bukur J; Lichtenfels R; Dammann R
    J Transl Med; 2009 Oct; 7():90. PubMed ID: 19857250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of expression of the ubiquitin carboxyl-terminal hydrolase L1 gene in human airway epithelium of cigarette smokers.
    Carolan BJ; Heguy A; Harvey BG; Leopold PL; Ferris B; Crystal RG
    Cancer Res; 2006 Nov; 66(22):10729-40. PubMed ID: 17108109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation.
    Ummanni R; Jost E; Braig M; Lohmann F; Mundt F; Barett C; Schlomm T; Sauter G; Senff T; Bokemeyer C; Sültmann H; Meyer-Schwesinger C; Brümmendorf TH; Balabanov S
    Mol Cancer; 2011 Oct; 10():129. PubMed ID: 21999842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer detection by ubiquitin carboxyl-terminal esterase L1 methylation in pancreatobiliary fluids.
    Kato N; Yamamoto H; Adachi Y; Ohashi H; Taniguchi H; Suzuki H; Nakazawa M; Kaneto H; Sasaki S; Imai K; Shinomura Y
    World J Gastroenterol; 2013 Mar; 19(11):1718-27. PubMed ID: 23555160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rescue of silenced UCHL1 and IGFBP4 expression suppresses clonogenicity of giant cell tumor-derived stromal cells.
    Fellenberg J; Sähr H; Liu L; Schönsiegel F; Depeweg D; Lehner B; Herr I
    Cancer Lett; 2013 Aug; 336(1):61-7. PubMed ID: 23603559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of hypermethylation in promoter region of ubiquitin carboxyl-terminal hydrolase L1 in human esophageal cancer].
    Yan WJ; Guo MZ; Yang YS
    Zhonghua Nei Ke Za Zhi; 2012 May; 51(5):390-3. PubMed ID: 22883340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ubiquitin peptidase UCHL1 induces G0/G1 cell cycle arrest and apoptosis through stabilizing p53 and is frequently silenced in breast cancer.
    Xiang T; Li L; Yin X; Yuan C; Tan C; Su X; Xiong L; Putti TC; Oberst M; Kelly K; Ren G; Tao Q
    PLoS One; 2012; 7(1):e29783. PubMed ID: 22279545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitin carboxyl-terminal hydrolase isozyme L1/UCHL1 suppresses epithelial-mesenchymal transition and is under-expressed in cadmium-transformed human bronchial epithelial cells.
    Wu DD; Xu YM; Chen DJ; Liang ZL; Chen XL; Hylkema MN; Rots MG; Li SQ; Lau ATY
    Cell Biol Toxicol; 2021 Aug; 37(4):497-513. PubMed ID: 33040242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin C-terminal hydrolase-L1 has prognostic relevance and is a therapeutic target for high-grade neuroendocrine lung cancers.
    Shimada Y; Kudo Y; Maehara S; Matsubayashi J; Otaki Y; Kajiwara N; Ohira T; Minna JD; Ikeda N
    Cancer Sci; 2020 Feb; 111(2):610-620. PubMed ID: 31845438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous expression and functional relevance of the ubiquitin carboxyl-terminal hydrolase L1 in melanoma.
    Wulfänger J; Biehl K; Tetzner A; Wild P; Ikenberg K; Meyer S; Seliger B
    Int J Cancer; 2013 Dec; 133(11):2522-32. PubMed ID: 23686552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant methylation of HTATIP2 and UCHL1 as a predictive biomarker for cholangiocarcinoma.
    Nanok C; Jearanaikoon P; Proungvitaya S; Limpaiboon T
    Mol Med Rep; 2018 Mar; 17(3):4145-4153. PubMed ID: 29359783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic silencing of microRNA-218 via EZH2-mediated H3K27 trimethylation is involved in malignant transformation of HBE cells induced by cigarette smoke extract.
    Wang B; Liu Y; Luo F; Xu Y; Qin Y; Lu X; Xu W; Shi L; Liu Q; Xiang Q
    Arch Toxicol; 2016 Feb; 90(2):449-61. PubMed ID: 25526925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitin C-terminal hydrolase L1 (UCHL1) regulates post-myocardial infarction cardiac fibrosis through glucose-regulated protein of 78 kDa (GRP78).
    Lei Q; Yi T; Li H; Yan Z; Lv Z; Li G; Wang Y
    Sci Rep; 2020 Jun; 10(1):10604. PubMed ID: 32606430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumor suppressor UCHL1 forms a complex with p53/MDM2/ARF to promote p53 signaling and is frequently silenced in nasopharyngeal carcinoma.
    Li L; Tao Q; Jin H; van Hasselt A; Poon FF; Wang X; Zeng MS; Jia WH; Zeng YX; Chan AT; Cao Y
    Clin Cancer Res; 2010 Jun; 16(11):2949-58. PubMed ID: 20395212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent CpG methylation of ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) in sporadic and hereditary Tunisian breast cancer patients: clinical significance.
    Trifa F; Karray-Chouayekh S; Jmaa ZB; Jmal E; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
    Med Oncol; 2013 Mar; 30(1):418. PubMed ID: 23315218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pivotal Role of Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) in Uterine Leiomyoma.
    Suzuki T; Dai Y; Ono M; Kojima J; Sasaki T; Fujiwara H; Kuji N; Nishi H
    Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin C-terminal hydrolase L1 promotes expression of programmed cell death-ligand 1 in non-small-cell lung cancer cells.
    Mao R; Tan X; Xiao Y; Wang X; Wei Z; Wang J; Wang X; Zhou H; Zhang L; Shi Y
    Cancer Sci; 2020 Sep; 111(9):3174-3183. PubMed ID: 32539182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin C-terminal hydrolase 1: A novel functional marker for liver myofibroblasts and a therapeutic target in chronic liver disease.
    Wilson CL; Murphy LB; Leslie J; Kendrick S; French J; Fox CR; Sheerin NS; Fisher A; Robinson JH; Tiniakos DG; Gray DA; Oakley F; Mann DA
    J Hepatol; 2015 Dec; 63(6):1421-8. PubMed ID: 26264933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.